NeurologyLive® Mind Moments®
NeurologyLive
Mind Moments®, a podcast from NeurologyLive® (https://www.neurologylive.com/) , brings you exclusive interviews with experts in neurologic disorders. Listen in to hear the latest clinical and research updates from major medical conferences, as well as insights on the management of complex disorders, including epilepsy, migraine, Alzheimer disease, stroke, multiple sclerosis, Parkinson disease, and more. For more expert insight into neurology, visit NeurologyLive.com (https://www.neurologylive.com/) .
Categorias: Educación
Añadir a Mi Lista
Escuchar el último episodio:
Episodios anteriores
-
125 - 113: Lessons Learned in Alzheimer Drug DevelopmentFri, 19 Apr 2024
-
124 - 112: Exploring Dimethyl Fumarate to Treat Friedreich AtaxiaFri, 05 Apr 2024
-
123 - Special Episode: FDA Approval of Givinostat for Duchenne Muscular DystrophyFri, 29 Mar 2024
-
122 - 111: Reviewing ACTRIMS 2024Fri, 22 Mar 2024
-
121 - 110: Differential Diagnosis of Sleep Disorders and HypersomniasFri, 08 Mar 2024
-
120 - 109: AB126, Exosomes, and Cerebroprotection for StrokeFri, 23 Feb 2024
-
119 - 108: Advancing the Genetic Pool of Parkinson DiseaseFri, 09 Feb 2024
-
118 - 107: Revealing Mechanisms of Sudden Unexplained Death in ToddlersFri, 26 Jan 2024
-
117 - 106: Potential Role of Stathmin-2 in Amyotrophic Lateral SclerosisFri, 12 Jan 2024
-
116 - 105: Recapping Conversations in Neurology From 2023Fri, 29 Dec 2023
-
115 - 104: Effects of Once-Nightly Sodium Oxybate on Narcolepsy Type 1 and 2Fri, 15 Dec 2023
-
114 - 103: Advancing Epilepsy Care and Seizure Localization in PediatricsFri, 01 Dec 2023
-
113 - 102: Potential of Gamma Sensory Stimulation in Alzheimer DiseaseFri, 17 Nov 2023
-
112 - Special Episode: FDA Greenlights Vamorolone for Duchenne Muscular DystrophyTue, 07 Nov 2023
-
111 - 101: Ways to Enhance Neuromodulation in ParkinsonismFri, 03 Nov 2023
-
110 - Special Episode: FDA Approves Zilucoplan for Myasthenia GravisMon, 23 Oct 2023
-
109 - 100: 2023 ECTRIMS-ACTRIMS Meeting HighlightsFri, 20 Oct 2023
-
108 - 99: Understanding AMX0035's Potential in Progressive Supranuclear PalsyThu, 05 Oct 2023
-
107 - 98: Uncovering Phenotypical Features of Narcolepsy Type 1Fri, 22 Sep 2023
-
106 - 97: Identifying Gaps in Access to Parkinson Disease CareFri, 08 Sep 2023
-
105 - 96: Complexities With Cognitive Screening in Primary Care SettingsFri, 25 Aug 2023
-
104 - Special Episode: Addition of Valbenazine to Treat Huntington Disease ChoreaMon, 21 Aug 2023
-
103 - 95: Expanding Potential for Long-Term Treatment in SMAFri, 11 Aug 2023
-
102 - 94: The Discussion Surrounding Lecanemab's Approval for Alzheimer DiseaseFri, 28 Jul 2023
-
101 - 93: Caring for Women With Parkinson DiseaseFri, 14 Jul 2023
-
100 - 92: Highlights From the 2023 CMSC, SLEEP, AHS, and ATMRD Annual MeetingsFri, 30 Jun 2023
-
99 - Special Episode: SRP-9001 Approved As First Gene Therapy for Duchenne Muscular DystrophyThu, 22 Jun 2023
-
98 - 91: Assessing the Landscape of Sleep Disorder CareFri, 16 Jun 2023
-
97 - 90: Raising Stroke Awareness and Improving Clinical CareFri, 02 Jun 2023
-
96 - 89: Potential of CNM-Au8 Gold Nanocrystals to Treat ALSFri, 19 May 2023
-
95 - 88: 2023 AAN Annual Meeting HighlightsFri, 05 May 2023
-
94 - Special Episode: Tofersen Approved for SOD1 ALSTue, 25 Apr 2023
-
93 - 87: Severe Multiple Sclerosis and the CASA-MS StudyFri, 21 Apr 2023
-
92 - 86: Pimavanserin and Atypical Antipsychotics to Treat Parkinson Disease PsychosisFri, 07 Apr 2023
-
91 - 85: Impact of Narcolepsy on Social Relationship Health in AdolescentsFri, 24 Mar 2023
-
90 - Special Episode: Trofinetide Approved for Rett SyndromeMon, 13 Mar 2023
-
89 - 84: Parkinson Disease Education for Community ProvidersFri, 10 Mar 2023
-
88 - 83: The ARISE Study and Using DMTs in RISFri, 24 Feb 2023
-
87 - 82: Managing Seizures After Ischemic StrokeFri, 10 Feb 2023
-
86 - 81: Widening the Therapeutic Window in Parkinson DiseaseFri, 27 Jan 2023
-
85 - 80: Advancing Treatment for Rare Neuromuscular DisordersFri, 13 Jan 2023
-
84 - Special Episode: Lecanemab Approved for Alzheimer DiseaseMon, 09 Jan 2023
-
83 - 79: A New Monoclonal for Alzheimer DiseaseFri, 16 Dec 2022
-
82 - 78: A Virtual Reality Platform for Parkinson DiseaseFri, 02 Dec 2022
-
81 - 77: A New Era of Myasthenia Gravis TreatmentFri, 18 Nov 2022
-
80 - 76: ECTRIMS 2022 and the Latest in MS AdvancesFri, 04 Nov 2022
-
79 - 75: Focusing on the Future of NeurologyFri, 21 Oct 2022
-
78 - 74: Prescription Digital Therapeutics for InsomniaFri, 07 Oct 2022
-
77 - 73: The Role of Palliative Care in NeurologyFri, 23 Sep 2022
-
76 - 72: Updates in Epilepsy TreatmentFri, 09 Sep 2022
Mostrar más episodios
5
